重组Anti-XRCC4抗体[EPR28958-63] (ab317697)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR28958-63] to XRCC4
- Suitable for: IHC-P, IP, WB
- Reacts with: Human
Related conjugates and formulations
概述
-
产品名称
Anti-XRCC4抗体[EPR28958-63]
参阅全部 XRCC4 一抗 -
描述
兔单克隆抗体[EPR28958-63] to XRCC4 -
宿主
Rabbit -
经测试应用
适用于: IHC-P, IP, WBmore details -
种属反应性
与反应: Human
不与反应: Mouse, Rat -
免疫原
Recombinant fragment. This information is proprietary to Abcam and/or its suppliers.
-
阳性对照
- WB: HeLa, HeLa transfected with siRNA specifically targeting XRCC4 whole cell lysate, Untreated HeLa, HeLa treated with 2uM staurosporine for 3h whole cell lysate, HCT 116, 293T cells, T-47D and Human tonsil lysates. IHC-P: Human tonsil, Human endometrioid carcinoma and Human breast tissues. IP: HeLa cell.
-
常规说明
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Avoid freeze / thaw cycle. -
存储溶液
pH: 7.2
Preservative: 0.01% Sodium azide
Constituents: 40% Glycerol (glycerin, glycerine), 59% PBS, 0.05% BSA -
Concentration information loading...
-
纯度
Protein A purified -
克隆
单克隆 -
克隆编号
EPR28958-63 -
同种型
IgG -
研究领域
相关产品
-
Alternative Versions
-
Compatible Secondaries
-
Isotype control
-
Related Products
应用
The Abpromise guarantee
Abpromise™承诺保证使用ab317697于以下的经测试应用
“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。
应用 | Ab评论 | 说明 |
---|---|---|
IHC-P |
1/500. Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
|
|
IP |
1/1000.
|
|
WB |
1/1000. Predicted molecular weight: 38 kDa.
|
说明 |
---|
IHC-P
1/500. Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. |
IP
1/1000. |
WB
1/1000. Predicted molecular weight: 38 kDa. |
靶标
-
功能
Involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination. Binds to DNA and to DNA ligase IV (LIG4). The LIG4-XRCC4 complex is responsible for the NHEJ ligation step, and XRCC4 enhances the joining activity of LIG4. Binding of the LIG4-XRCC4 complex to DNA ends is dependent on the assembly of the DNA-dependent protein kinase complex DNA-PK to these DNA ends. -
组织特异性
Widely expressed. -
序列相似性
Belongs to the XRCC4 family. -
翻译后修饰
Phosphorylated by PRKDC. The phosphorylation seems not to be necessary for binding to DNA. Phosphorylation by CK2 promotes interaction with APTX.
Monoubiquitinated.
Sumoylation at Lys-210 is required for nuclear localization and recombination efficiency. Has no effect on ubiquitination. -
细胞定位
Nucleus. - Information by UniProt
-
数据库链接
- Entrez Gene: 7518 Human
- Omim: 194363 Human
- SwissProt: Q13426 Human
- Unigene: 567359 Human
-
别名
- DNA double strand break repair and V(D)J recombination protein XRCC4 antibody
- DNA repair protein XRCC4 antibody
- SSMED antibody
see all
图片
-
All lanes : Anti-XRCC4 antibody [EPR28958-63] (ab317697) at 1/1000 dilution
Lane 1 : HeLa (human cervical adenocarcinoma epithelial cell) transfected with scrambled siRNA control whole cell lysate
Lane 2 : HeLa transfected with siRNA specifically targeting XRCC4 whole cell lysate
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution
Predicted band size: 38 kDa
Observed band size: 35,55 kDa why is the actual band size different from the predicted?
Exposure time: 48 secondsBlocking and diluting buffer and concentration: 5% NFDM/TBST.
Lysates were freshly made and used for Western blotting immediately to minimize protein degradation.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
-
All lanes : Anti-XRCC4 antibody [EPR28958-63] (ab317697) at 1/1000 dilution
Lane 1 : Untreated heLa (human cervical adenocarcinoma epithelial cell) whole cell lysate
Lane 2 : HeLa treated with 2uM staurosporine for 3h whole cell lysate
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution
Predicted band size: 38 kDa
Observed band size: 35,55 kDa why is the actual band size different from the predicted?
Exposure time: 15 secondsBlocking and diluting buffer and concentration: 5% NFDM/TBST.
The expression of caspase cleaved XRCC4 is upregulated upon induction of apoptosis (PMID: 33725486).
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
-
All lanes : Anti-XRCC4 antibody [EPR28958-63] (ab317697) at 1/1000 dilution
Lanes 1 & 6 : HCT 116 (human colorectal carcinoma epithelial cell) whole cell lysate
Lanes 2 & 5 : HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate
Lanes 3 & 7 : 293T (human embryonic kidney epithelial cell) whole cell lysate
Lane 4 : T-47D (human ductal breast epithelial tumor epithelial cell) whole cell lysate
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 38 kDa
Observed band size: 55 kDa why is the actual band size different from the predicted?
Exposure time: 15 secondsBlocking and diluting buffer and concentration: 5% NFDM/TBST.
In Lane 1-Lane 4, lysates were freshly made and used for Western blotting immediately to minimize protein degradation.
-
Anti-XRCC4 antibody [EPR28958-63] (ab317697) at 1/1000 dilution + Human tonsil tissue lysate at 20 µg
Secondary
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 38 kDa
Observed band size: 55 kDa why is the actual band size different from the predicted?
Exposure time: 70 secondsBlocking and diluting buffer and concentration: 5% NFDM/TBST.
-
Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labeling XRCC4 with ab317697 at 1/500 (1.032 ug/ml) dilution, followed by a ready to use LeicaDS9800 (Bond Polymer Refine Detection).
Positive staining in human tonsil.
The section was incubated with ab317697 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrumentCounterstained with Hematoxylin.
Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
-
Immunohistochemical analysis of paraffin-embedded Human endometrioid carcinoma tissue labeling XRCC4 with ab317697 at 1/500 (1.032 ug/ml) dilution, followed by a ready to use LeicaDS9800 (Bond Polymer Refine Detection).
Positive staining in human endometrioid carcinoma.
The section was incubated with ab317697 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrumentCounterstained with Hematoxylin.
Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
-
Immunohistochemical analysis of paraffin-embedded Human breast tissue labeling XRCC4 with ab317697 at 1/500 (1.032 ug/ml) dilution, followed by a ready to use LeicaDS9800 (Bond Polymer Refine Detection).
Positive staining in human breast.
The section was incubated with ab317697 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrumentCounterstained with Hematoxylin.
Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
-
XRCC4 was immunoprecipitated from 0.35 mg HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate with ab317697 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab317697 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution.
Lane 1: HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate
Lane 2: ab317697 IP in HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate
Lane 3: Rabbit monoclonal IgG (ab172730) instead of ab317697 in HeLa whole cell lysateBlocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 50 seconds.
实验方案
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
数据表及文件
-
SDS download
-
Datasheet download
Certificate of Compliance
文献 (0)
ab317697 尚未被引用在任何文献中。